BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fattahi S, Nikbakhsh N, Taheri H, Ghadami E, Kosari-monfared M, Amirbozorgi G, Asouri M, Pilehchian-langroudi M, Ranaee M, Samadani AA, Paryan M, Akhavan-niaki H. Prevalence of multiple infections and the risk of gastric adenocarcinoma development at earlier age. Diagnostic Microbiology and Infectious Disease 2018;92:62-8. [DOI: 10.1016/j.diagmicrobio.2018.04.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Mansour-Ghanaei F, Samadi A, Joukar F, Tirgar Fakheri H, Hassanipour S, Ashoobi MT, Soltanipour S, Alizadeh A, Rezamand G, Fathalipour M. Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial. EXCLI J 2019;18:644-52. [PMID: 31611747 DOI: 10.17179/excli2019-1613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wang H, Chen XL, Liu K, Bai D, Zhang WH, Chen XZ, Hu JK; SIGES research group. Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies.Clin Transl Gastroenterol. 2020;11:e00201. [PMID: 32764207 DOI: 10.14309/ctg.0000000000000201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Fattahi S, Golpour M, Amjadi-Moheb F, Sharifi-Pasandi M, Khodadadi P, Pilehchian-Langroudi M, Ashrafi GH, Akhavan-Niaki H. DNA methyltransferases and gastric cancer: insight into targeted therapy. Epigenomics. 2018;10:1477-1497. [PMID: 30325215 DOI: 10.2217/epi-2018-0096] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
4 Wang H, Chen XZ, Chen XL, Zhang WH, Liu K, Wang YJ, Tang HR, Hu JK; SIGES research group. Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A hospital-based, case-control study (SIGES). Cancer Med 2021;10:3741-55. [PMID: 33934530 DOI: 10.1002/cam4.3901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Norollahi SE, Foumani MG, Pishkhan MK, Shafaghi A, Alipour M, Jamkhaneh VB, Marghoob MN, Vahidi S. DNA Methylation Profiling of MYC, SMAD2/3 and DNMT3A in Colorectal Cancer. Oman Med J 2021;36:e315. [PMID: 34804598 DOI: 10.5001/omj.2020.93] [Reference Citation Analysis]
6 Fattahi S, Nikbakhsh N, Ranaei M, Sabour D, Akhavan-Niaki H. Association of sonic hedgehog signaling pathway genes IHH, BOC, RAB23a and MIR195-5p, MIR509-3-5p, MIR6738-3p with gastric cancer stage. Sci Rep 2021;11:7471. [PMID: 33811245 DOI: 10.1038/s41598-021-86946-0] [Reference Citation Analysis]
7 Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sci 2020;262:118513. [PMID: 33011222 DOI: 10.1016/j.lfs.2020.118513] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
8 Palrasu M, Zaika E, El-Rifai W, Que J, Zaika AI. Role of Bacterial and Viral Pathogens in Gastric Carcinogenesis. Cancers (Basel) 2021;13:1878. [PMID: 33919876 DOI: 10.3390/cancers13081878] [Reference Citation Analysis]
9 Baghbanian M, Hoseini Mousa SA, Doosti M, Moghimi M. Association between Gastric Pathology and Hepatitis B Virus Infection in Patients with or without Helicobacter Pylori. Asian Pac J Cancer Prev 2019;20:2177-80. [PMID: 31350982 DOI: 10.31557/APJCP.2019.20.7.2177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Babaei K, Khaksar R, Zeinali T, Hemmati H, Bandegi A, Samidoust P, Ashoobi MT, Hashemian H, Delpasand K, Talebinasab F, Naebi H, Mirpour SH, Keymoradzadeh A, Norollahi SE. Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer. Biomedicine (Taipei) 2019;9:22. [PMID: 31724937 DOI: 10.1051/bmdcn/2019090422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yang Y, Jiang Z, Wu W, Ruan L, Yu C, Xi Y, Wang L, Wang K, Mo J, Zhao S. Chronic Hepatitis Virus Infection Are Associated With High Risk of Gastric Cancer: A Systematic Review and Cumulative Analysis. Front Oncol 2021;11:703558. [PMID: 34307172 DOI: 10.3389/fonc.2021.703558] [Reference Citation Analysis]
12 Norollahi SE, Mansour-Ghanaei F, Joukar F, Ghadarjani S, Mojtahedi K, Gharaei Nejad K, Hemmati H, Gharibpoor F, Khaksar R, Samadani AA. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy. Biomed Pharmacother. 2019;115:108958. [PMID: 31075731 DOI: 10.1016/j.biopha.2019.108958] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chen C, Chen S, Han Z, Xie W, Zhang T, Mao C, Zhang L, Sun X, Kwok T, Shen X, Xue X. Patients with Helicobacter pylori-positive gastric cancer with human cytomegalovirus infection have a low tendency of advanced lymphatic metastasis in a Chinese population. Oncol Lett 2021;21:402. [PMID: 33777225 DOI: 10.3892/ol.2021.12663] [Reference Citation Analysis]
14 Sonkar C, Varshney N, Koganti S, Jha HC. Kinases and therapeutics in pathogen mediated gastric cancer. Mol Biol Rep 2022. [PMID: 35031925 DOI: 10.1007/s11033-021-07063-9] [Reference Citation Analysis]
15 Mansour-Ghanaei F, Joukar F, Baghaee M, Sepehrimanesh M, Hojati A. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer. Biomol Concepts 2019;10:82-90. [PMID: 31188744 DOI: 10.1515/bmc-2019-0010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
16 Mohebbi A, Mamizadeh Z, Bagheri H, Sharifnezhad F, Tabarraei A, Yazdi M. Prevalent latent human cytomegalovirus genotype b2 in biopsy samples of gastric cancer. Future Virology 2020;15:71-8. [DOI: 10.2217/fvl-2019-0117] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ghadami E, Nikbakhsh N, Fattahi S, Kosari‐monfared M, Ranaee M, Taheri H, Amjadi‐moheb F, Godazandeh G, Shafaei S, Nosrati A, Pilehchian Langroudi M, Samadani AA, Amirbozorgi G, Mirnia V, Akhavan‐niaki H. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections. J Cell Physiol 2019;234:4115-24. [DOI: 10.1002/jcp.27220] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
18 Joukar F, Mavaddati S, Mansour-Ghanaei F, Samadani AA. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. J Gastrointest Cancer 2020;51:363-78. [PMID: 31025167 DOI: 10.1007/s12029-019-00237-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
19 Fattahi S, Kosari‐monfared M, Ghadami E, Golpour M, Khodadadi P, Ghasemiyan M, Akhavan‐niaki H. Infection‐associated epigenetic alterations in gastric cancer: New insight in cancer therapy. J Cell Physiol 2018;233:9261-70. [DOI: 10.1002/jcp.27030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
20 Han XL, Yi CL, Ma JD, He Y, Wu LM, Wang YF, Yang HJ, Liang DY, Shi JF. Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer. Lab Med 2021:lmab035. [PMID: 34508270 DOI: 10.1093/labmed/lmab035] [Reference Citation Analysis]
21 Fattahi S, Nikbakhsh N, Taheri H, Ghadami E, Ranaee M, Akhavan-Niaki H. LINC02688 and PP7080 as novel biomarkers in early diagnosis of gastric cancer. Noncoding RNA Res 2021;6:86-91. [PMID: 33997538 DOI: 10.1016/j.ncrna.2021.04.002] [Reference Citation Analysis]
22 Samadani AA, Norollahi SE, Rashidy-pour A, Mansour-ghanaei F, Nemati S, Joukar F, Afshar AM, Ghazanfari S, Safizadeh M, Rostami P, Gatei M. Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells. Biomedicine & Pharmacotherapy 2018;108:590-9. [DOI: 10.1016/j.biopha.2018.09.048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
23 Fattahi S, Kosari-Monfared M, Golpour M, Emami Z, Ghasemiyan M, Nouri M, Akhavan-Niaki H. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine. J Cell Physiol. 2020;235:3189-3206. [PMID: 31595495 DOI: 10.1002/jcp.29260] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]